Pattern Of Isolated Fungi From Bronchoalveolar Lavage Among Patients With Bronchial Asthma
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This study is to assess the pattern of isolated fungi from the respiratory air way (bronchial tree) from bronchoalvealar lavage (BAL) in asthmatic patients with uncontrolled or difficult to treat asthma
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2024
CompletedFirst Posted
Study publicly available on registry
April 19, 2024
CompletedStudy Start
First participant enrolled
April 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2025
CompletedApril 19, 2024
April 1, 2024
12 months
April 16, 2024
April 18, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
assess the pattern of isolated fungi from the respiratory air way (bronchial tree) from bronchoalvealar lavage (BAL) in asthmatic patients with uncontrolled or difficult to treat asthma
BAL will stained by fungal staining with lactophenol stain as well as culture on Sabouraud dextrose agar.
1 year
Study Arms (1)
Study patern of fungal inection which cause excerbation
OTHERTake bal through fob and send for fungal stain and culure
Interventions
take bal through fibrooptic bronchoscopy and send for stain and culcure
Eligibility Criteria
You may qualify if:
- Age 18 years or more.
- Patients with Uncontrolled bronchial asthma, frequent exacerbations and difficult to treat symptoms despite adherence to medication.
You may not qualify if:
- Age less than 18 years.
- Patients who do not give consent for the procedure.
- Patients with unstable cardiac conditions (recent myocardial infarction, cardiac arrhythmia, etc.)
- Pregnant women.
- Patient already on antifungal treatment.
- Bleeding profile abnormality.
- patients during acute sever attacks .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of chest medicine
Study Record Dates
First Submitted
April 16, 2024
First Posted
April 19, 2024
Study Start
April 25, 2024
Primary Completion
April 20, 2025
Study Completion
May 20, 2025
Last Updated
April 19, 2024
Record last verified: 2024-04